Josh Bilenker
Operating Partner at Aisling Capital
About
Bilenker, an MD, joined Aisling in 2006 and has been an Operating Partner since 2014. He served as CEO of portfolio company Loxo Oncology until its acquisition by Eli Lilly and is now CEO and co-founder of Treeline Biosciences. He holds an MD from Johns Hopkins and an AB from Princeton.
Colleagues at Aisling Capital
Aftab Kherani
Operating Partner at Aisling Capital
Andrew Schiff
Managing Partner at Aisling Capital
Carol Zikopoulos
Head of Human Resources and Compliance Manager at Aisling Capital
Eric Aguiar
Partner at Aisling Capital
Hannah Wieder
Controller at Aisling Capital
Katie Tansey
Vice President of Investor Relations and Marketing at Aisling Capital
Robert Wenzel
Chief Financial Officer and Chief Compliance Officer at Aisling Capital
Scott Braunstein
Operating Partner at Aisling Capital